Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma
Evitar a utilizao em caso de gravidez, amamentao, antecedentes oncolgicos ou condies mdicas complexas
Reported Side Effects (Mild and Rare) Nausea Occasionally reported when injected near the stomach or when dosing is too high Headache Often from stacking with other peptides (e.g., GH secretagogues) Dizziness or lightheadedness Linked to vasodilation or nitric oxide regulation Injection site irritation Mild redness or swelling is possible with subcutaneous use These effects are usually short-lived and self-resolving , especially when using proper injection technique and sterile reconstitution practices
Pull back on the syringe plunger to draw up the amount of water you need, which is typically between 0.5 milliliters (ml) and 2 ml, depending on the instructions specific to your peptide
Consult a licensed medical provider before making any decisions related to your health
Ma PC, Maulik G, Christensen J, Salgia R (2003)